Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Tax Provisions (2023 - 2025)

Eton Pharmaceuticals' Tax Provisions history spans 3 years, with the latest figure at -$69000.0 for Q4 2025.

  • On a quarterly basis, Tax Provisions fell 179.31% to -$69000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $43000.0, a 186.67% increase, with the full-year FY2025 number at $43000.0, up 186.67% from a year prior.
  • Tax Provisions hit -$69000.0 in Q4 2025 for Eton Pharmaceuticals, down from -$28000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for ETON hit a ceiling of $247000.0 in Q4 2023 and a floor of -$126000.0 in Q3 2024.
  • Historically, Tax Provisions has averaged $38125.0 across 3 years, with a median of $60000.0 in 2024.
  • The widest YoY moves for Tax Provisions: up 77.78% in 2025, down 179.31% in 2025.
  • Tracing ETON's Tax Provisions over 3 years: stood at $247000.0 in 2023, then crashed by 64.78% to $87000.0 in 2024, then plummeted by 179.31% to -$69000.0 in 2025.
  • Business Quant data shows Tax Provisions for ETON at -$69000.0 in Q4 2025, -$28000.0 in Q3 2025, and $66000.0 in Q2 2025.